The goal of this study is to evaluate the Salah Azaïz Cancer Institute male breast cancer patients population over a period of 14 years. Goal of the retrospective part: to gather clinicopathologic data and follow-up outcomes of male breast cancer patients diagnosed and/or treated at Salah Azaïz Cancer Institute from 2004 to 2013. Goal of the prospective part: to create a registry of male patients with breast cancer for a period of 48 months (from 2014 to 2017).
Study Type
OBSERVATIONAL
Enrollment
150
Salah Azaïz Cancer Institute
Tunis, Tunisia
Clinical outcomes
Survival, Disease free survival
Time frame: Through study completion, an average of 4 year
Clinico-biological characteristics of the disease
Time frame: Through study completion, an average of 4 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.